SCHEMBL25645368

SCHEMBL25645368

CN(S)Cc1ccc(N(C)C)cc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 0.58
TSHR P16473 4/20 0.58
MAPK1 P28482 3/20 0.58
CYP3A4 P08684 2/20 0.58
TDP1 Q9NUW8 2/20 0.58
ALOX15 P16050 2/20 0.52
HSD17B10 Q99714 2/20 0.52
SLC2A1 P11166 1/20 0.43
MEN1 O00255 1/20 0.43
KMT2A Q03164 1/20 0.43
TP53 P04637 1/20 0.42
RAB9A P51151 1/20 0.42
CALM1 P0DP23 1/20 0.41
HRH3 Q9Y5N1 1/20 0.41
G6PC1 P35575 1/20 0.41
KDM4E B2RXH2 2/20 0.40
GAA P10253 2/20 0.40
CNR2 P34972 1/20 0.40
APP P05067 1/20 0.40
NPC1 O15118 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12414402 0.80 ALDH1A1 (0.64) ALDH1A1TSHRMAPK1CYP3A4TDP1
SCHEMBL384906 0.80 ALDH1A1 (0.64) ALDH1A1TSHRMAPK1CYP3A4TDP1
SCHEMBL19033246 0.77 ALDH1A1 (0.54) ALDH1A1TSHRMAPK1CYP3A4TDP1
SCHEMBL28075013 0.76 PYCR1 (0.52) ALDH1A1TSHRRAB9AHRH3KDM4E
SCHEMBL21078333 0.76 ALDH1A1 (0.58) ALDH1A1TSHRMAPK1CYP3A4TDP1
SCHEMBL25588075 0.76 PYCR1 (0.52) ALDH1A1TDP1HRH3
SCHEMBL11086907 0.75 ALDH1A1 (0.64) ALDH1A1TSHRMAPK1CYP3A4TDP1
SCHEMBL28074416 0.75 TSHR (0.64) ALDH1A1TSHRCYP3A4RAB9AKDM4E
SCHEMBL21078332 0.74 ALDH1A1 (0.56) ALDH1A1TSHRMAPK1CYP3A4TDP1
SCHEMBL17886950 0.74 ALDH1A1 (0.56) ALDH1A1TSHRMAPK1CYP3A4TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11679158-B2 Biodegradable lipids for the delivery of active agents ALNYLAM PHARMACEUTICALS, INC. (US) 2023-06-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11679158-B2 Biodegradable lipids for the delivery of active agents LIPA, APOB, CETP ALDH1A1 3151/4885TSHR 2733/4885MAPK1 4707/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.